![A line drawing of a laptop and a cup of coffee](/sites/default/files/2020-12/hero-laptop.png)
Articles in this supplement focus on the global opioid crisis, including coverage of harm reduction approaches, health justice promotion, and lessons learned.
Articles in this supplement focus on the global opioid crisis, including coverage of harm reduction approaches, health justice promotion, and lessons learned.
This publication describes the recent trends of drug overdose deaths in the United States (U.S.) and the benefits of adopting harm reduction approaches.
In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.
This document provides a quick overview of the federal discretionary funding programs that support essential aspects of the nation’s HIV response.
In May, the New England AIDS Education Training Center (NEAETC) published a set of pages dedicated to providing information about and resources for HIV and HIV-related topics.
Clinicians can now access up-to-date evidence-based office-based addiction treatment recommendations for treating opioid use disorder (OUD) on a smartphone app.
Achieving the goals of the Ending the HIV Epidemic (EHE) Initiative depends on doing more to strengthen communities, reduce the harm associated with drug use, and prevent disease transmission.
Because of naloxone’s ability to reverse opioid overdose and its ease of use, by July 15, 2017, all 50 states and the District of Columbia had passed legislation to improve naloxone access, as one strategy to reduce opioid overdose morbidity and mortality.
This webinar describes systemic barriers faced by patients with HIV and substance use disorders, and discusses steps providers can take to decrease these barriers and support integration of behavioral health and HIV public health interventions.
To address the infectious disease consequences of the opioid crisis in the U.S., a public workshop titled Integrating Infectious Disease Considerations with Response to the Opioid Epidemic was convened on March 12 and 13, 2018, by the National Academies of Sciences, Engineering, and Medicine.